Read by QxMD icon Read

Psychoeducation schizophrenia insight

F Sauvanaud, O Kebir, M Vlasie, V Doste, I Amado, M-O Krebs
INTRODUCTION: In schizophrenic disorders, supportive psychosocial therapies have been used as adjuncts to pharmacotherapy to help alleviate residual symptoms and to improve social functioning and quality of life. Among these therapies, psychoeducational therapies showed a significant efficacy on improving drug adherence and on reducing relapses. However, according to the French Health Agency, fewer than 10% of psychiatric structures in France offer registered psychoeducation programs...
September 19, 2016: L'Encéphale
Nicolas Franck
Schizophrenia is characterized not only by symptoms, but also by a reduced insight that contributes to functional outcomes through a bad acceptation of the disease and a low involvement in treatment and care. Functional outcomes of schizophrenia are conditioned by the acceptance of the troubles, by the involvement in psychopharmacological treatment and in psychosocial care and by the expressed emotion level of the family. Psychoeducation improves adherence to treatment. Psychoeducation lowers relapse rate. All the patients suffering from schizophrenia and their families should benefit from psychoeducation...
September 2016: La Presse Médicale
Lisa Wood, Rory Byrne, Filippo Varese, Anthony P Morrison
It is acknowledged that people with a schizophrenia-spectrum diagnosis experience higher levels of stigma compared to any other mental health diagnosis. As a consequence, their experience of internalised stigma is likely to be the most detrimental and pervasive. Internalised stigma interventions have shown some benefits in those who experience serious mental illness including those with a schizophrenia-spectrum diagnosis. A systematic narrative review and meta-analysis were conducted examining the efficacy of internalised stigma interventions for people with a schizophrenia-spectrum diagnosis...
October 2016: Schizophrenia Research
Matthew J Smith, Jan S Greenberg, Sarah A Sciortino, Gisela M Sandoval, Ellen P Lukens
BACKGROUND: Research suggests siblings of individuals with schizophrenia are at a heightened risk for depressive symptomatology. Research has not yet examined whether the strains of growing up with a brother or sister with schizophrenia contribute to this risk. This study examined whether early life course burdens associated with an emerging mental illness, and current objective and subjective caregiver burden predicted depressive symptoms in siblings of individuals with schizophrenia...
2016: Mental Health in Family Medicine
Stephanie V Phan
Medication nonadherence is common among patients with schizophrenia and due to a variety of factors including lack of insight, psychopathology, substance use disorder, issues associated with treatment, stigma, fragmentation of care, cultural influences, and socioeconomic status. Among this population, nonadherence is problematic because it can lead to decompensation or exacerbation of symptoms, relapse, rehospitalization or greater use of emergency psychiatric services, functional decline, and increased risk of death...
2016: International Journal of Psychiatry in Medicine
John A Naslund, Lisa A Marsch, Gregory J McHugo, Stephen J Bartels
BACKGROUND: Serious mental illness (SMI) is one of the leading causes of disability worldwide. Emerging mobile health (mHealth) and eHealth interventions may afford opportunities for reaching this at-risk group. AIM: To review the evidence on using emerging mHealth and eHealth technologies among people with SMI. METHODS: We searched MEDLINE, PsychINFO, CINAHL, Scopus, Cochrane Central, and Web of Science through July 2014. Only studies which reported outcomes for mHealth or eHealth interventions, defined as remotely delivered using mobile, online, or other devices, targeting people with schizophrenia, schizoaffective disorder, or bipolar disorder, were included...
2015: Journal of Mental Health
Christian von Maffei, Frauke Görges, Werner Kissling, Wolfgang Schreiber, Christine Rummel-Kluge
BACKGROUND: Relapses and, subsequently, readmissions are common in patients with schizophrenia. Psychoeducation has been shown to reduce the number and duration of readmissions. Yet, only little more than 20% of psychiatric patients in German speaking countries receive psychoeducation. Among other reasons, costs may be considered too high by hospitals. The objective of the present study was to test the feasibility of a new cost-efficient approach in the psychoeducation of patients with schizophrenia...
2015: BMC Psychiatry
Sai Zhao, Stephanie Sampson, Jun Xia, Mahesh B Jayaram
BACKGROUND: Those with serious/severe mental illness, especially schizophrenia and schizophrenic-like disorders, often have little to no insight regarding the presence of their illness. Psychoeducation may be defined as the education of a person with a psychiatric disorder regarding the symptoms, treatments, and prognosis of that illness. Brief psychoeducation is a short period of psychoeducation; although what constitutes 'brief psychoeducation' can vary. A previous systematic review has shown that the median length of psychoeducation is around 12 weeks...
2015: Cochrane Database of Systematic Reviews
Stéphane Raffard, Catherine Bortolon, Alexandra Macgregor, Joanna Norton, Jean-Philippe Boulenger, Mohamad El Haj, Delphine Capdevielle
BACKGROUND: Clinical insight in schizophrenia patients is partly associated with familial environment but has been poorly studied to date. We aimed to explore (1) the relationship between parents' cognitive insight and their offspring's; (2) the relationship between parents' cognitive insight and their clinical insight into the disease of their offspring; and (3) the clinical and cognitive determinants of cognitive insight in parents. METHODS: Cognitive insight was assessed in 37 patient-biological parent pairs/dyads with the Beck Cognitive Insight Scale (BCIS)...
November 2014: Schizophrenia Research
Peter M Haddad, Cecilia Brain, Jan Scott
Nonadherence with medication occurs in all chronic medical disorders. It is a particular challenge in schizophrenia due to the illness's association with social isolation, stigma, and comorbid substance misuse, plus the effect of symptom domains on adherence, including positive and negative symptoms, lack of insight, depression, and cognitive impairment. Nonadherence lies on a spectrum, is often covert, and is underestimated by clinicians, but affects more than one third of patients with schizophrenia per annum...
2014: Patient related Outcome Measures
Steffen Moritz, Christina Andreou, Brooke C Schneider, Charlotte E Wittekind, Mahesh Menon, Ryan P Balzan, Todd S Woodward
The present article provides a narrative review of empirical studies on metacognitive training in psychosis (MCT). MCT represents an amalgam of cognitive-behavioral therapy (CBT), cognitive remediation (CRT) and psychoeducation. The intervention is available in either a group (MCT) or an individualized (MCT+) format. By sowing the seeds of doubt in a playful and entertaining fashion, the program targets positive symptoms, particularly delusions. It aims to raise patients' awareness for common cognitive traps or biases (e...
June 2014: Clinical Psychology Review
Wai Tong Chien, David R Thompson
BACKGROUND: Psychoeducation programmes for people with schizophrenia are shown to reduce relapses but few studies have indicated significant improvements in patients' illness awareness and insight, functioning, symptom severity or rates of readmission to hospital. AIMS: To examine the effects of a mindfulness-based psychoeducation programme for Chinese people with schizophrenia. METHOD: A multisite randomised controlled trial was conducted with 107 out-patients with schizophrenia: 36 and 35 received a 6-month mindfulness-based psychoeducation and a conventional psychoeducation programme, respectively, and 35 received routine care alone...
July 2014: British Journal of Psychiatry: the Journal of Mental Science
David Misdrahi, Sophie Denard, Joel Swendsen, Isabelle Jaussent, Philippe Courtet
Improving insight in patients with schizophrenia appears necessary to enhance medication adherence and clinical outcome, but in some patients acquiring insight can paradoxically increase hopelessness, depression and suicidal behavior. The aim of this study is to explore the association of two dimensions of insight (cognitive and clinical) with depression, hopelessness and clinical variables in patients with psychosis. Using a cross-sectional design, 61 remitted outpatients meeting DSM-IV criteria for schizophrenia or schizoaffective disorders were included...
April 30, 2014: Psychiatry Research
Mads G Henriksen, Josef Parnas
Poor insight into illness is considered the primary cause of treatment noncompliance in schizophrenia. In this article, we critically discuss the predominant conceptual accounts of poor insight, which consider it as an ineffective self-reflection, caused either by psychological defenses or impaired metacognition. We argue that these accounts are at odds with the phenomenology of schizophrenia, and we propose a novel account of poor insight. We suggest that the reason why schizophrenia patients have no or only partial insight and consequently do not comply with treatment is rooted in the nature of their anomalous self-experiences (ie, self- disorders) and the related articulation of their psychotic symptoms...
May 2014: Schizophrenia Bulletin
Iglika V Vassileva, Vihra K Milanova
OBJECTIVE: Attitude toward antipsychotic medication is considered as one of the main predictors for medication adherence in schizophrenia. The present non-interventional cross-sectional study aims to explore the associations between attitudes toward antipsychotic medication, insight and other clinical variables in outpatients with schizophrenia. METHOD: Attitudes toward antipsychotic medication, clinical and social variables, sociodemographic and illness-related characteristics were assessed via a set of semi-structured clinical interviews and self-rating scales in a total of 226 patients with schizophrenia on a long-term antipsychotic treatment in community based settings...
October 2012: Folia Medica
Wai-Tong Chien, Sau-Fong Leung
The study reported herein a randomized controlled trial was conducted to test the effectiveness of a nurse-led, needs-based psycho-education program for Chinese patients with first-onset mental illness over a 6-month follow-up. Ninety-six families of Chinese patients with schizophrenia newly referred to one outpatient clinic in Hong Kong were randomly assigned to a nurse-led psycho-education program or usual outpatient care, each comprising 48 subjects. The patients' mental health, illness insight, self-efficacy, services utilization, and hospitalization rates were measured at recruitment and at one week and six months post-intervention...
February 2013: International Journal of Nursing Practice
Wai Tong Chien, Isabella Y M Lee
OBJECTIVES: This study tested the effectiveness of a mindfulness-based psychoeducation program for Chinese outpatients with schizophrenia over an 18-month follow-up. The program is a psychoeducational program that addresses patients' awareness and knowledge of schizophrenia and builds skills for illness management. METHODS: A multisite controlled trial was conducted with 96 Chinese patients with schizophrenia in Hong Kong. They were randomly assigned to either the mindfulness-based psychoeducation program or usual psychiatric care...
April 1, 2013: Psychiatric Services: a Journal of the American Psychiatric Association
Toshiro Uchino, Masaharu Maeda, Naohisa Uchimura
Previous studies suggest that self-stigma is related to social isolation and discrimination. Although it is known that stigma has cultural and social impacts, only a few studies in Japan have explored self-stigma in people with schizophrenia. The present study was conducted to investigate self-stigma in people with schizophrenia and schizoaffective disorder in Japan under a typical clinical setting, and to examine the effect of psychoeducation on self-stigma. Fifty-six participants (44 men and 12 women) who met the DSM-IV criteria for schizophrenia and schizoaffective disorder were recruited...
2012: Kurume Medical Journal
Maritta Välimäki, Heli Hätönen, Mari Lahti, Lauri Kuosmanen, Clive E Adams
BACKGROUND: Poor compliance with treatment often means that many people with schizophrenia or other severe mental illness relapse and may need frequent and repeated hospitalisation. Information and communication technology (ICT) is increasingly being used to deliver information, treatment or both for people with severe mental disorders. OBJECTIVES: To evaluate the effects of psychoeducational interventions using ICT as a means of educating and supporting people with schizophrenia or related psychosis...
2012: Cochrane Database of Systematic Reviews
César Carvajal
In psychiatry, one of the main factors contributing to poor response to pharmacological treatment is adherence. Noncompliance with maintenance treatments for chronic illnesses such as schizophrenia and affective disorders can exceed 50%, Poor adherence can be due to drug-related factors (tolerance, complexity of prescription, side effects, or cost), patient-related variables (illness symptoms, comorbidity, insight capacity, belief system, or sociocultural environment), and physician-related factors (communication or psychoeducational style)...
March 2004: Dialogues in Clinical Neuroscience
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"